ME02668B - Postupak za izdvajanje nalmefen hidrohlorida - Google Patents

Postupak za izdvajanje nalmefen hidrohlorida

Info

Publication number
ME02668B
ME02668B MEP-2017-75A MEP201775A ME02668B ME 02668 B ME02668 B ME 02668B ME P201775 A MEP201775 A ME P201775A ME 02668 B ME02668 B ME 02668B
Authority
ME
Montenegro
Prior art keywords
phase
nalmefene hydrochloride
aqueous composition
process according
aqueous
Prior art date
Application number
MEP-2017-75A
Other languages
German (de)
English (en)
French (fr)
Unknown language (me)
Inventor
Faveri Carla De
Mariano Stivanello
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02668(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of ME02668B publication Critical patent/ME02668B/me

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MEP-2017-75A 2011-12-06 2012-12-06 Postupak za izdvajanje nalmefen hidrohlorida ME02668B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567148P 2011-12-06 2011-12-06
DKPA201100948 2011-12-06
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride
EP12797909.4A EP2788357B1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (1)

Publication Number Publication Date
ME02668B true ME02668B (me) 2017-06-20

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2017-75A ME02668B (me) 2011-12-06 2012-12-06 Postupak za izdvajanje nalmefen hidrohlorida

Country Status (32)

Country Link
US (1) US8841452B1 (enEXAMPLES)
EP (1) EP2788357B1 (enEXAMPLES)
JP (1) JP6086925B2 (enEXAMPLES)
KR (1) KR20140103288A (enEXAMPLES)
CN (1) CN104093721B (enEXAMPLES)
AR (1) AR089080A1 (enEXAMPLES)
AU (1) AU2012347261B2 (enEXAMPLES)
BR (1) BR112014013541B1 (enEXAMPLES)
CA (1) CA2857096C (enEXAMPLES)
CL (1) CL2014001454A1 (enEXAMPLES)
CO (1) CO6970605A2 (enEXAMPLES)
CY (1) CY1118785T1 (enEXAMPLES)
DK (1) DK2788357T3 (enEXAMPLES)
ES (1) ES2622156T3 (enEXAMPLES)
HR (1) HRP20170497T1 (enEXAMPLES)
HU (1) HUE033717T2 (enEXAMPLES)
IL (1) IL232826A (enEXAMPLES)
IN (1) IN2014KN01211A (enEXAMPLES)
JO (1) JO3251B1 (enEXAMPLES)
LT (1) LT2788357T (enEXAMPLES)
ME (1) ME02668B (enEXAMPLES)
MX (1) MX354331B (enEXAMPLES)
PL (1) PL2788357T3 (enEXAMPLES)
PT (1) PT2788357T (enEXAMPLES)
RS (1) RS55817B1 (enEXAMPLES)
RU (1) RU2631652C2 (enEXAMPLES)
SG (1) SG11201402956UA (enEXAMPLES)
SI (1) SI2788357T1 (enEXAMPLES)
SM (1) SMT201700200T1 (enEXAMPLES)
TW (1) TWI560170B (enEXAMPLES)
WO (1) WO2013083685A1 (enEXAMPLES)
ZA (1) ZA201404100B (enEXAMPLES)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
US20240109907A1 (en) 2021-01-28 2024-04-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3896226A (en) * 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
ATE500257T1 (de) * 1999-11-09 2011-03-15 Abbott Lab Hydromorphinonzusammensetzungen
MXPA04008772A (es) * 2002-03-14 2004-12-06 Euro Celtique Sa Composiciones de clorhidrato de naltrexona.
AU2007224221B2 (en) * 2006-03-02 2013-02-14 SpecGx LLC Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
CN101652370A (zh) * 2006-12-04 2010-02-17 诺拉姆科有限公司 制备14-羟基可待因酮水平减少的羟考酮的方法
WO2008094574A2 (en) 2007-01-30 2008-08-07 Biogen Idec Ma Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
BRPI1010975B1 (pt) 2009-05-25 2021-08-24 H. Lundbeck A/S Métodos para preparar nalmefeno a partir de naltrexona em uma reação de wittig e para isolar o nalmefeno
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
JP2015504856A (ja) 2015-02-16
CA2857096A1 (en) 2013-06-13
CN104093721A (zh) 2014-10-08
ES2622156T3 (es) 2017-07-05
IL232826A (en) 2016-10-31
HRP20170497T1 (hr) 2017-06-02
WO2013083685A1 (en) 2013-06-13
CA2857096C (en) 2021-01-19
EP2788357B1 (en) 2017-03-01
MX2014006705A (es) 2014-07-09
KR20140103288A (ko) 2014-08-26
CY1118785T1 (el) 2017-07-12
RU2631652C2 (ru) 2017-09-26
DK2788357T3 (en) 2017-04-24
IN2014KN01211A (enEXAMPLES) 2015-10-16
AU2012347261B2 (en) 2016-12-01
SG11201402956UA (en) 2014-07-30
CN104093721B (zh) 2016-05-18
AR089080A1 (es) 2014-07-30
ZA201404100B (en) 2015-11-25
US20140296525A1 (en) 2014-10-02
PL2788357T3 (pl) 2017-07-31
AU2012347261A1 (en) 2014-06-19
BR112014013541B1 (pt) 2022-02-15
BR112014013541A2 (pt) 2017-06-13
TW201335110A (zh) 2013-09-01
PT2788357T (pt) 2017-04-24
IL232826A0 (en) 2014-08-03
LT2788357T (lt) 2017-04-25
HUE033717T2 (en) 2017-12-28
RS55817B1 (sr) 2017-08-31
JP6086925B2 (ja) 2017-03-01
RU2014126489A (ru) 2016-01-27
JO3251B1 (ar) 2018-09-16
US8841452B1 (en) 2014-09-23
EP2788357A1 (en) 2014-10-15
CO6970605A2 (es) 2014-06-13
MX354331B (es) 2018-02-27
TWI560170B (en) 2016-12-01
SMT201700200T1 (it) 2017-05-08
CL2014001454A1 (es) 2014-10-03
SI2788357T1 (sl) 2017-06-30
HK1202874A1 (en) 2015-10-09

Similar Documents

Publication Publication Date Title
ME02668B (me) Postupak za izdvajanje nalmefen hidrohlorida
ME02316B (me) Imidazopiridazini kao inhibitori akt kinaze
ME02622B (me) Pripremanje nalmefen hidrohlorida od naltreksona
MX2015002752A (es) Metodo de preparación de una d,l-metionina limpia.
JP2012527489A5 (enEXAMPLES)
JP2017501141A5 (enEXAMPLES)
WO2013079507A3 (de) Verfahren zur herstellung und aufreinigung von salzen der acrylamido-2-methyl-propansulfonsäure
ME02621B (me) Postupak za proizvodnju naltreksona
JP2013100237A5 (enEXAMPLES)
CN104003978B (zh) 贝他斯汀或其消旋化合物的工业化制备方法
CN103936759B (zh) (3aS,6aR)-1,3-二苄基-四氢-4H-噻吩并[3,4-d]咪唑-2,4-(1H)-二酮的简便制备方法
WO2013016557A3 (en) Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids
CN103555969B (zh) 一种钾钠分离新方法
FI20106311A0 (fi) Menetelmä orgaanisen hapon talteenottamiseksi laimeasta vesiliuoksesta
HRP20171166T1 (hr) Postupak za pripravu intermedijera pirimidina
CN104892501A (zh) 一种3-[(3-氨基-4-甲氨基苯甲酰基)(吡啶-2-基)氨基]丙酸乙酯的后处理纯化方法
CN104447345B (zh) 一种噁草酮醚化废盐渣再利用的处理方法
JP2012193074A5 (enEXAMPLES)
WO2008108442A1 (ja) 新規ポルフィラジン誘導体およびその中間体、新規ポルフィラジン誘導体およびその中間体の製造方法、並びにその利用
CN108610247A (zh) 6-氯-7-羟基-1-茚酮的制备方法
WO2018099600A9 (en) A method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagent
CN104418792A (zh) 一种化合物6-甲基吲哚-3-甲醛的制备方法
CN105777827A (zh) 一种高纯度红霉素e的提取方法
TH135193A (th) วิธีการสำหรับการผลิตอะโรมาติคไดฟอสเฟต
TH173416A (th) "วิธีการนำผลึกกรดซัคซินิกกลับคืนมาโดยใช้สารลดแรงตึงผิวระหว่างการตกผลึก และผลึกที่ได้"